Home / Aprepitant / Czechia
CZ ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in Czechia
Is there an Aprepitant shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Aprepitant product is reported short in Czechia, the first since 1 Sep 2025. The company estimate for the return is 1 May 2027. Main reason: manufacturing problem.
Also short in United States, Canada, Germany, France, Italy, Spain, Ireland, Austria, Norway, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | APREPITANT ACCORD 80MG+125MG 80MG+125MG CPS DUR 2+1 | Accord (Intas) | 1 Sep 2025 | 1 May 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.